BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Gatos Silver, Inc. (NYSE - GATO), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. (Nasdaq - AVTE)

/EIN News/ -- BALA CYNWYD, Pa., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Poseida Therapeutics, Inc. (Nasdaq – PSTX)

Under the terms of the agreement, Poseida will be acquired by Roche Holdings, Inc. (“Roche”) for $9.00 per share in cash at closing, plus a non-tradeable CVR to receive certain contingent payments of up to an aggregate of $4.00 per share in cash upon achievement of specific milestones. This corresponds to a total equity value of approximately $1.5 billion on a fully diluted basis. The investigation concerns whether the Poseida Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Roche is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/poseida-therapeutics-inc-nasdaq-pstx/.

Aerovate Therapeutics, Inc. (Nasdaq - AVTE)

Under the terms of the agreement, Aerovate will be acquired by Jade Biosciences (“Jade”). Pre-merger Aerovate stockholders are expected to own approximately 1.6% of the combined company, while pre-merger Jade stockholders — including those investors participating in the pre-closing financing — are expected to own approximately 98.4% of the combined entity. The investigation concerns whether Aerovate Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Jade is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/aerovate-therapeutics-inc-nasdaq-avte/.

Gatos Silver, Inc. (NYSE - GATO)

Under the terms of the agreement, Gatos Silver will be acquired by First Majestic Silver Corp. (“First Majestic”) (NYSE -AG) (TSX - AG) (FSE -FMV). Gatos Silver shareholders will receive 2.550 common shares of First Majestic for each common share of Gatos Silver held. The consideration implies a total offer value of US$13.49 per common share of Gatos based on the closing price of First Majestic’s common shares on the NYSE on September 4, 2024,

The investigation concerns whether the Gatos Silver Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether First Majestic is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/gatos-silver-inc-nyse-gato/.

Micropac Industries, Inc. (OTC - MPAD)

Under the terms of the agreement, Micropac will be acquired by Teledyne for $20.00 per share in cash. The investigation concerns whether the Micropac Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Teledyne is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/micropac-industries-inc-otc-mpad/

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.